Catheter Precision, Inc. Net Fee Amt
Catheter Precision, Inc. (VTAK) had Net Fee Amt of $8.93 thousand as of 2026-06-18, per its S-1 filed 2026-06-22.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-06-22
- 2026-06-18: Net Fee Amt $8.93K.
| Period end | Net Fee Amt |
|---|---|
| 2026-06-18 | $8.93K S-1 · filed 2026-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |